Single dose fluconazole in the treatment of pityriasis versicolor
Keywords:
Single dose, fluconazole, pityriasis versicolorAbstract
Objectives To evaluate the efficacy and safety of single dose (450mg) of fluconazole in the treatment of pityriasis versicolor. Patients and methods Patients suffering from pityriasis versicolor presenting to department of dermatology, Hayatabad Medical Complex,Peshawar were enrolled in the study. Diagnosis of PV was made by Wood’s lamp and confirmed by examination of scales in KOH preparation. 30 patients were included in the study. Results 30 patients completed the study including 24 males and 6 females. Their age ranged from 14 years to 45 years (mean 25.3 years). Eighteen patients (60%) had complete cure and their clinical and laboratory parameters remained negative at 3 weeks and 6 weeks after completion of treatment. Twelve (40%) had no response to treatment. Treatment was well-tolerated and there were no adverse affects reported with single 450mg of fluconazole. Conclusion Fluconazole 450mg as a single dose was effective in the treatment of pityriasis versicolor and well tolerated. However, long term comparative studies should be done to establish the efficacy of fluconazole as a single dose treatment in PV.References
Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 1998; 55: 645-74.
Gupta AK, Batra R, Bluhm R. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004; 51: 785-98.
Gupta AK, Ryder JE, Nicol K. Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis. Clin Dermatol 2003; 21: 417-25.
Savin R. Diagnosis and treatment of tinea versicolor. J Fam Prac 1996;43: 127,
Karakas M, Durdu M, Memisoglu HR. Oral fluconazole in the treatment of tinea versicolor. J Dermatol 2005; 32: 19-21.
Ashbee HR, Evans EG: Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 2002; 15: 21-57.
Drake LA, Dinehart SM, Farmer ER et al. Guidelines of care for superficial mycotic infections of the skin: Pityriasis (tinea) versicolor. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol 1996; 34: 287-9.
Shahid J, Ihsan Z, Khan S. Oral fluconazole in the treatment of pityriasis versicolor. J Derm Treat 2000; 11: 101-13.
Partap R, Kaur I, Chakrabarti A, Kumar B. Single-dose fluconazole versus itraconazole in pityriasis versicolor. Dermatology 2004; 208: 55-9.
Faergemann J. Tinea versicolor (pityriasis versicolor). In: Demis DJ, ed. Clinical Dermatology. Philadelphia: Lippincott-Raven; 1995. p. 3(17-2), 1-11.
